Unaudited Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Collaboration revenue	$ 0	$ 1,252
Operating expenses:
Research and development	25,055	14,070
General and administrative	9,842	7,343
Total operating expenses	34,897	21,413
Loss from operations	(34,897)	(20,161)
Other income:
Interest income	11,389	5,401
Total other income	11,389	5,401
Net loss	(23,508)	(14,760)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities, net	1,593	(1,189)
Comprehensive loss	$ (21,915)	$ (15,949)
Net loss per common share, basic	$ (0.38)	$ (0.3)
Net loss per common share, diluted	$ (0.38)	$ (0.3)
Weighted-average shares of common stock outstanding, basic	61,791,721	49,049,741
Weighted-average shares of common stock outstanding, diluted	61,791,721	49,049,741